McIver Zachariah bought JANX
January 2, 2025 · Form 4 insider transaction
McIver Zachariah bought 26,000 shares of Janux Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
26,000
Price
$0.00
Total value
N/A
InsiderMcIver Zachariah
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJanuary 2, 2025
Filing dateJanuary 3, 2025
Shares owned after26,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest in four equal annual installments beginning on January 1, 2026.